<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>swiinc</title><link>https://investorshangout.com/profile/view?id=64051</link><description><![CDATA[swiinc]]></description><language>en-us</language><pubDate>Fri, 11 Sep 2026 17:43:11 GMT</pubDate><copyright>Copyright InvestorsHangout.com</copyright><atom:link href="https://investorshangout.com/profile/view?id=64051" rel="self" type="application/rss+xml"/><item><title>swiinc: From the august 04 PR &quot;The DSMC reviewed compiled</title><link>https://investorshangout.com/post/view?id=5929767</link><guid>https://investorshangout.com/post/view?id=5929767</guid><description><![CDATA[swiinc
]]></description><pubDate>Wed, 14 Oct 2020 18:26:02 GMT</pubDate></item><item><title>swiinc: criteria for stopping a trial prematurely.</title><link>https://investorshangout.com/post/view?id=5925810</link><guid>https://investorshangout.com/post/view?id=5925810</guid><description><![CDATA[swiinc
]]></description><pubDate>Sun, 11 Oct 2020 04:02:01 GMT</pubDate></item><item><title>swiinc: if LL performs anywhere close to oncoimmunes</title><link>https://investorshangout.com/post/view?id=5914226</link><guid>https://investorshangout.com/post/view?id=5914226</guid><description><![CDATA[swiinc
]]></description><pubDate>Thu, 01 Oct 2020 03:54:35 GMT</pubDate></item><item><title>swiinc: If CD12 performs similar to CD10 NEWS2 score over</title><link>https://investorshangout.com/post/view?id=5912195</link><guid>https://investorshangout.com/post/view?id=5912195</guid><description><![CDATA[swiinc
]]></description><pubDate>Tue, 29 Sep 2020 20:12:03 GMT</pubDate></item></channel></rss>